Advancing Tailored Treatments: A Predictive Nomogram, Based on Ultrasound and Laboratory Data, for Assessing Nodal Involvement in Endometrial Cancer Patients
Authors:
- Ida PinoIPIda Pino
- Elisa GozziniEGElisa Gozzini
- Davide RadiceDRDavide Radice
- Sara BoveriSBSara Boveri
- Anna Daniela IacoboneAnna Daniela Iacobone
- Ailyn Mariela Vidal UrbinatiAUAilyn Mariela Vidal Urbinati
- Francesco MultinuFMFrancesco Multinu
- Giuseppe GulloGiuseppe Gullo
- Gaspare CucinellaGaspare Cucinella
- Dorella FranchiDFDorella Franchi
Open Access
- 16 January 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (2) , 496
Abstract
Assessing lymph node metastasis is crucial in determining the optimal therapeutic approach for endometrial cancer (EC). Considering the impact of lymphadenectomy, there is an urgent need for a cost-effective and easily applicable method to evaluate the risk of lymph node metastasis in cases of sentinel lymph node (SLN) biopsy failure. This retrospective monocentric study enrolled EC patients, who underwent surgical staging with nodal assessment. Data concerning demographic, clinicopathological, ultrasound, and surgical characteristics were collected from medical records. Ultrasound examinations were conducted in accordance with the IETA statement. We identified 425 patients, and, after applying exclusion criteria, the analysis included 313 women. Parameters incorporated into the nomogram were selected via univariate and multivariable analyses, including platelet count, myometrial infiltration, minimal tumor-free margin, and CA 125. The nomogram exhibited good accuracy in predicting lymph node involvement, with an AUC of 0.88. Using a cutoff of 10% likelihood of nodal involvement, the nomogram displayed a low false-negative rate of 0.04 (95% CI 0.00–0.19) in the training set. The adaptability of this straightforward model renders it suitable for implementation across diverse clinical settings, aiding gynecological oncologists in preoperative patient evaluations and facilitating the design of personalized treatments. However, external validation is mandatory for confirming diagnostic accuracy.Keywords
This publication has 66 references indexed in Scilit:
- Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer StagingInternational Journal of Gynecological Cancer, 2013
- A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancerAmerican Journal of Obstetrics and Gynecology, 2012
- Tumour‐free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancerBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodesGynecologic Oncology, 2012
- Evaluation of cervical involvement in endometrial cancer by transvaginal sonography, magnetic resonance imaging and frozen sectionJournal of Obstetrics and Gynaecology, 2010
- Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) groupUltrasound in Obstetrics & Gynecology, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- Evaluation of lymph nodes with RECIST 1.1European Journal of Cancer, 2009
- Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinomaGynecologic Oncology, 2008
- Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imagingUltrasound in Obstetrics & Gynecology, 2008